Emanual Maverakis | |
---|---|
Born | |
Education | Medicine |
Alma mater | |
Awards | |
Scientific career | |
Fields | Immunogenetics |
Institutions | |
Thesis | Mhc-guided processing: binding of large antigen fragments (2003) |
Emanual Maverakis is an American physician-scientist and immunologist specializing in immunogenetics. He is a professor at the University of California, Davis.
Emanual Maverakis was born in Oakland, California, and spent his early childhood in South Central Los Angeles. His family later relocated to Moorpark, California, where he attended high school. Maverakis is of mixed heritage: his mother's family immigrated from Jalisco, Mexico, and his father's family immigrated from Crete.
Although Maverakis would become an accomplished academic, he did not immediately pursue higher education after high school. Instead, he spent three years working as a security guard. He eventually completed his undergraduate studies at the University of California, Los Angeles (UCLA), where he worked with and was mentored by the late Eli Sercarz, PhD, a notable immunologist. Maverakis graduated from UCLA with departmental honors and the Latin distinction summa cum laude.
Concerned about Maverakis' rough vernacular, Dr. Sercarz recommended that he delay matriculation to Harvard Medical School for one year, which Maverakis agreed to. During medical school, Maverakis continued his research efforts and spent a year as a Howard Hughes Medical Institute Student Research Fellow at the La Jolla Institute for Immunology between his second and third years. He graduated from Harvard Medical School in 2003 with an MD summa cum laude, becoming one of only 15 medical students in Harvard's 237-year history to achieve the highest honors. [1]
Maverakis joined the United States Department of Veterans Affairs in 2007, where he held a joint appointment as an assistant professor in residence at the University of California, Davis. After six years with the VA, he relocated his laboratory and clinical duties to the University of California, Davis, where he is now a full professor in the Department of Dermatology. His research team is known for their work in predictive modeling and the development of novel analysis tools in immunogenetics.
As a principal investigator, Maverakis has received several prestigious awards, including the NIH Director's New Innovator Award, the Presidential Early Career Award for Scientists and Engineers from President Barack Obama, and early career awards from the Burroughs Wellcome Fund and the Howard Hughes Medical Institute. He is also an elected honorary fellow of the California Academy of Sciences (2019) and the American Association for the Advancement of Science (2023). In 2022, he was elected to the American Society for Clinical Investigation. [2] [3] [4] [5]
Latin honours are a system of Latin phrases used in some colleges and universities to indicate the level of distinction with which an academic degree has been earned. The system is primarily used in the United States. It is also used in some Southeastern Asian countries with European colonial history, such as Indonesia and the Philippines, and African countries such as Zambia and South Africa, although sometimes translations of these phrases are used instead of the Latin originals. The honours distinction should not be confused with the honors degrees offered in some countries, or with honorary degrees.
Baldomero Olivera is a Filipino chemist known for discovery of many cone snail toxins important for neuroscience. These molecules, called conotoxins, led to a breakthrough in the study of ion channels and neuromuscular synapses. He discovered and first characterized E. coli DNA ligase, a key enzyme of genetic engineering and recombinant DNA technology.
David S. Eisenberg is an American biochemist and biophysicist best known for his contributions to structural biology and computational molecular biology. He has been a professor at the University of California, Los Angeles since the early 1970s and was director of the UCLA-DOE Institute for Genomics & Proteomics, as well as a member of the California NanoSystems Institute (CNSI) at UCLA.
Charles Alderson Janeway, Jr. (1943–2003) was an American immunologist who helped create the modern field of innate immunity. A member of the National Academy of Sciences, he held a faculty position at Yale University's Medical School and was an Howard Hughes Medical Institute Investigator.
The Gruber Prize in Genetics, established in 2001, is one of three international awards worth US$500,000 made by the Gruber Foundation, a non-profit organization based at Yale University in New Haven, Connecticut.
Howard Minions Radzely is an American lawyer who served as the United States Deputy Secretary of Labor from December 19, 2007 through February 2, 2009.
Kevin R. Johnson is the Dean of the UC Davis School of Law. Before becoming a professor, he was a student at Harvard Law School where he served as an editor of the Harvard Law Review, served as a clerk to Judge Stephen Reinhardt of the United States Court of Appeals for the Ninth Circuit, and worked for law firm Heller Ehrman White & McAuliffe. Johnson joined the faculty at the UC Davis School of Law in 1989, was named Associate Dean in 1998, and the Dean in 2008. Of Mexican American ancestry, he is the first Latino to head a law school in the UC system.
Utpal Banerjee is a distinguished professor of the department of molecular, cell and developmental biology at UCLA. He obtained his Bachelor of Science degree in chemistry from St. Stephen's College, Delhi University, India and obtained his Master of Science degree in physical chemistry from the Indian Institute of Technology, Kanpur, India. In 1984, he obtained a PhD in chemistry from the California Institute of Technology where he was also a postdoctoral Fellow in the laboratory of Seymour Benzer from 1984-1988.
George Quentin Daley is the Dean of the Faculty of Medicine, Caroline Shields Walker Professor of Medicine, and Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School. He was formerly the Robert A. Stranahan Professor of Pediatrics at Harvard Medical School, Director of the Stem Cell Transplantation Program at Boston Children's Hospital, and an investigator of the Howard Hughes Medical Institute, Associate Director of Children's Stem Cell Program, a member of the Executive Committee of the Harvard Stem Cell Institute. He is a past president of the International Society for Stem Cell Research (2007–2008).
Zhijian "James" Chen is a Chinese-American biochemist and professor in the department of molecular biology at University of Texas Southwestern Medical Center. He is best known for his discovery of mechanisms by which nucleic acids trigger innate and autoimmune responses from the interior of a cell, work for which he received the 2019 Breakthrough Prize in Life Sciences.
Jay Shendure is an American scientist and human geneticist at the University of Washington. He is a professor in the Department of Genome Sciences at the University of Washington School of Medicine and an Affiliate Investigator in the Human Biology Division at the Fred Hutchinson Cancer Research Center. Shendure's research is focused on developing and applying new technologies in genomics. In 2005, his doctoral research with George M. Church resulted one of the first successful proof-of-concepts of next-generation DNA sequencing. Shendure's research group at the University of Washington pioneered exome sequencing and its application to Mendelian disorders, a strategy that has been applied to identify hundreds of disease-causing genes. Other notable accomplishments of Shendure's laboratory include the first whole genome sequencing of a human fetus using samples obtained non-invasively from the parents, and the sequencing of the HeLa genome in agreement with Henrietta Lacks' family.
David Howard Sachs is an American immunologist. He is best known for his discovery of MHC class II and for his seminal studies in the fields of transplant immune tolerance and xenotransplantation.
Akiko Iwasaki is a Sterling Professor of Immunobiology and Molecular, Cellular and Developmental Biology at Yale University. She is also a principal investigator at the Howard Hughes Medical Institute. Her research interests include innate immunity, autophagy, inflammasomes, sexually transmitted infections, herpes simplex virus, human papillomavirus, respiratory virus infections, influenza infection, T cell immunity, commensal bacteria, COVID-19, and long COVID.
Barry R. Bloom is Joan L. and Julius H. Jacobson Professor of Public Health, Emeritus in the Department of Immunology and Infectious Diseases and Department of Global Health and Population in the Harvard T.H. Chan School of Public Health, where he served as dean of the faculty from 1998 through December 31, 2008.
Claudio Pellegrini is an Italian/American physics and emeritus professor at University of California, Los Angeles (UCLA), known for his pioneering work on X-ray free electron lasers and collective effects in relativistic particle beams.
Carl O. Pabo is a biophysicist. He is the founder and president of Humanity 2050, a nonprofit institute.
Eero Simoncelli is an American computational neuroscientist and Silver Professor at New York University. He was a Howard Hughes Medical Institute Investigator from 2000 to 2020. In 2020, he became the inaugural director of the Center for Computational Neuroscience at the Flatiron Institute of the Simons Foundation.
Daniel David Federman, was an American endocrinologist and the Carl W. Walter Distinguished Professor of Medicine and the dean for medical education at Harvard Medical School. He helped change medical education at through its New Pathway curriculum around the early 1990s, and his work helped create the field of genetic endocrinology. Federman also worked for over thirty years at Boston's Brigham and Women's Hospital, a Harvard Medical School teaching hospital in the Longwood Medical and Academic Area.
Alexander Marson is an American biologist and infectious disease doctor who specializes in genetics, human immunology, and genome engineering. He is the Director of the Gladstone-UCSF Institute of Genomic Immunology, and a tenured Professor with a dual appointment in the Department of Medicine and the Department of Microbiology & Immunology at the University of California, San Francisco (UCSF).
Collin M. Stultz is an American biomolecular engineer, physician-scientist and academic at the Massachusetts Institute of Technology and the Massachusetts General Hospital. He is the Nina T. and Robert H. Rubin Professor in Medical Engineering and Science at MIT, a Professor of Electrical Engineering and Computer Science also at MIT, a faculty member in the Harvard-MIT Division of Health Sciences and Technology, and a cardiologist at the Massachusetts General Hospital. He is also co-Director of the Harvard–MIT Program in Health Sciences and Technology